Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LVS vs GSK✓SelectedUSD · GSKLVS vs GSK performance historyLatest closeAs of+0.15%11/19
Stock and ETF performance explorer

LVS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-37.0%
GSK return
+5.3%
Excess return
-42.3%
Maximum drawdown
-47.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.2%-1.6%+1.7%+0.5%
7D0.0%-4.7%+4.7%+1.0%
30D+3.9%-4.7%+8.6%+4.7%
3M-14.9%-8.8%-6.1%-13.6%
6M-20.1%-4.6%-15.4%-19.4%
YTD-38.0%+1.0%-39.0%-37.0%
1Y-37.0%+6.9%-43.9%-36.1%
All-37.0%+5.3%-42.3%-36.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling